31 min listen
Struggling with the Silent Killer: An Honest Look at How Demanding Oncology Trials Have Become with Rebecca Setta
Struggling with the Silent Killer: An Honest Look at How Demanding Oncology Trials Have Become with Rebecca Setta
ratings:
Length:
29 minutes
Released:
Apr 20, 2021
Format:
Podcast episode
Description
Rebecca Setta is an Associate Director at OncoSec whose 13 years of experience in clinical trials have given her the benefit of several different perspectives. Rebecca began her career on the vendor side, and her continuous pursuit of development and higher-level understanding led her to transition to the CRO space in 2015. Her role at OncoSec represents the natural evolution of a career shaped around an inherent desire for growth through further immersion in clinical trials.In Rebecca’s years of experience at the project level, she consistently found building effective teams to be among the most rewarding elements of her work. She now brings that expertise to bear at the department level, where she can act as a mentor, shaping a team to build on her knowledge and experience. Episode HighlightsHow Rebecca helps her team avoid burnout in a grueling fieldThe common characteristics she saw across the sites that adapted best at the start of the pandemicThe crucial change in mindset that she’s encouraged in her CRAsThe COVID-inflicted adaptations she expects to persist post-pandemicWhy it’s important to partner with sitesThe unexpected upside to the pandemic adjustments her sites have madeWhat really impresses her about the industryHow remote work and limited face time can impact morale, and one way she compensates for thatHow the weighty context of oncology research can also translate to motivationWhy she is so excited about the future of the industryResourceshttps://oncosec.comhttps://www.linkedin.com/company/oncosec-medical-inc/https://twitter.com/oncosec
Released:
Apr 20, 2021
Format:
Podcast episode
Titles in the series (12)
What We Learned from the Clin Ops Nightmares of 2020 with Kunal Sampat of Ceribell: In this episode, Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, speaks with Kunal Sampat of Ceribell, and discusses the changing landscape of clinical trial operations. An experienced Clinical Operations Director, Kunal shares his key learnings from 2020 and elaborates on some of the successes and challenges he’s seen this year. Industry stakeholders from CROs to site managers to sponsors will benefit from Kunal’s thoughtful advice and informed take on the current and future state of clinical operations. by Conversations in Clinical Trial Readiness